News – Page 867 – Endpoints News

Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO

6 years ago

A name emerges out of the Gilead M&A rumor mill, and it’s a cancer biotech

6 years ago

Biogen makes another bold Alzheimer’s bet, dropping $350M upfront to partner with genome-editing focused Sangamo

6 years ago

Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?

6 years ago

Another hiccup for GW Pharma's seizure drug rival, as Zogenix discloses FDA review delay

6 years ago

FDA taps chemoradio-sensitizing head and neck cancer drug as 'breakthrough'

6 years ago

A 9/11-era Omaha facility, an old Ebola drug, and the ubiquitous Dr. Fauci: Inside the first US novel coronavirus ...

6 years ago

Tessa gets RMAT designation for new CAR-T; FDA adcomm narrowly votes to expand Eli Lilly NSCLC label

6 years ago

UK follicular lymphoma patients set to get non-chemotherapy therapy as NICE backs Revlimid combo

6 years ago

Spark loses another top exec in the wake of $4.3B takeover by Roche — report

6 years ago

'The headlines are the headlines, but': BioMarin talks up potential savings as hemophilia gene therapy launch looms

6 years ago

Acacia Pharma's twice spurned drug finally makes the FDA cut

6 years ago

Following US, China hospital efforts, Gilead plots its own PhIII trials for closely watched Covid-19 drug

6 years ago

Scott Gottlieb in the running for possible coronavirus czar; The drug Vanda sued the FDA over fails a pivotal study

6 years ago

In at least one life-sci hub, gender and diversity initiatives haven’t made a dent

6 years ago

Will a 'risk-off' mindset hasten cell therapy M&A? Iovance surges on buyout chatter

6 years ago

One less rival for Immunovant, as Alexion abandons FcRn inhibitor

6 years ago

FDA monitoring 20 drugs at risk of shortage due to coronavirus

6 years ago

Clinical trial sponsors have to disclose decade’s worth of unreleased data, federal judge rules

6 years ago

Microbiome Q&A: New study maps the vagina's 'optimal microbiota' — and its implications for biopharma

6 years ago

Tying basic science to spinouts, Dana-Farber debuts sister funds totaling $126M with MPM Capital

6 years ago

Takeda swoops in to buy little biotech partner and its celiac drug poised to 'change standard of care'

6 years ago

Theft victim or data bully? IQVIA exchanges blows with small rival it says destroyed evidence in legal fight

6 years ago

In final report, ICER appears to have a change of heart on new acute migraine therapies

6 years ago

First page Previous page 864 865 866867868 869 870 Next page Last page